ArticleBlood advances2022

Impact of MRD status in patients with AML undergoing allogeneic stem cell transplantation in the first vs the second remission.

Madlen Jentzsch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.